An executive order called for a reduction in childhood vaccines, prompting pushback from health care providers.

Researchers evaluated the effects of biologic and targeted synthetic DMARDs on patient-reported outcomes in rheumatoid arthritis.

Updated CHEST guidelines offer 13 conditional recommendations for managing adult bronchiectasis and reducing exacerbation frequency ...

Despite a higher symptom burden, multimodal and multidisciplinary treatment is underutilized in older patients with chronic pain ...

Continued low-dose glucocorticoid maintenance therapy in ANCA-associated vasculitis does not reduce major relapse risk but can increase damage accrual.

The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.

Researchers evaluated the efficacy of secukinumab plus a glucocorticoid taper for achieving sustained remission in polymyalgia rheumatica.

Higher body mass index is linked to reduced odds of achieving minimal disease activity in psoriatic arthritis.

Erica Schwartz, MD, MPH, JD, becomes the new CDC director as the nation faces surging measles cases and parasitic outbreaks.

Ultra-high frequency ultrasound of the labial salivary glands may accurately classify Sjögren disease and reduce the need for biopsy.

Healthy plant-based diets are associated with lower CVD, T2D, and mortality risks regardless of food processing levels.

In adults with type 2 diabetes, use of GLP-1 receptor agonists is associated with an increased risk for incident nonscarring alopecia.